Reading Time: 6 minutesNew and effective treatments for MND are urgently needed and many scientists around the world are working towards this goal. Throughout 2024, we saw many
Search Results for: clinical trial

UK clinical trial updates to look out for in 2025
Reading Time: 6 minutesNew and effective treatments for MND are urgently needed and many scientists around the world are working towards this. Throughout 2024, we saw many new

Reading Time: 5 minutes"New drug reduces risk of death by 50%"
You may have seen this type of headline in news articles reporting on the outcome of clinical trials. Reading this headline can lead people to believe a potential drug is highly beneficial and has a real impact. However, it is important to delve a little deeper into the meaning of ‘risk of death’, the raw data behind it, and how it should be considered alongside other outcome measures of a trial to fully determine how effective a drug might be.

Reading Time: 6 minutesOver the past couple of years, the pace of MND research has continued to increase. In the last year alone, we saw an increase in

Reading Time: 6 minutesOn the 8 September 2023, members of the Research Development team at the MND Association attended the 4th UCL Queen Square Motor Neuron Disease Centre

Reading Time: 6 minutesQurAlis, a biotechnology company focused on developing precision medicines for MND and other neurodegenerative diseases, has announced the opening of a clinical trial in the

Reading Time: 7 minutesClinical trials are vital in the hunt for effective treatments of motor neurone disease. They provide the evidence needed to determine whether a drug is

Reading Time: 5 minutesThe MND clinical trial landscape has grown vastly over the last decade and this has led to increased opportunities for people with MND to take

Reading Time: 6 minutesMND is a complex disease, and the causes are still not fully understood. Researchers all around the world are working tirelessly on different theories to

Reading Time: 4 minutesA new clinical trial, investigating Dazucorilant, for the treatment of MND is now open for recruitment in the UK. With this trial, there are now